No Data
Changchun BCHT Biotechnology Co.'s (SHSE:688276) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
BaiKe Biological (688276.SH): DeepSeek has not yet been deployed.
Gelonghui, March 7th丨 Baike Biological (688276.SH) stated on the investor interaction platform that the company has not yet deployed DeepSeek, but will continue to monitor the latest technological advancements and their applications in relevant fields.
Baike Biotech: Changchun Baike Biotech Co., Ltd. 2024 Annual Performance Report Announcement
Changchun Baike Biotechnology Co., Ltd. 2024 Annual Performance Report Announcement
Baike Biological (688276.SH): Net income for the fiscal year 2024 decreased by 52.31% year-on-year.
On February 25, Gelonghui reported that Baike Biology (688276.SH) announced its performance preliminary report for the fiscal year 2024. During the reporting period, the company's total operating revenue was 1.229 billion yuan, a year-on-year decrease of 32.64%; the net income attributable to the parent company's owners was 0.239 billion yuan, a year-on-year decrease of 52.31%; the net income attributable to the parent company's owners after deducting non-recurring gains and losses was 0.237 billion yuan, a year-on-year decrease of 52.06%. The changes in performance for the fiscal year 2024 were mainly affected by factors such as the reduced willingness of the public to receive vaccinations and decreased market demand, significantly impacting the sales and use of the company's live attenuated varicella vaccine.
Changchun BCHT Biotechnology Deputy General Manager Quits
Investors Still Waiting For A Pull Back In Changchun BCHT Biotechnology Co. (SHSE:688276)